Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion

Journal of Virology

Volumn 69, Issue 6, 1995, Pages 3308-3314

  Schaal, Heiner ^a   Klein, Michael ^a   Gehrmann, Peter ^a   Adams, Ortwin ^a   Scheid, Andreas ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Inst for Med Microbiol/Virology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 41;

AMINO TERMINAL SEQUENCE; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE FUSION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; VIRUS ISOLATION; VIRUS MORPHOLOGY; VIRUS MUTATION;

EID: 0029062097     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.69.6.3308-3314.1995     Document Type: Article

References (61)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Adams, O., H. Scbaal, and A. Scheid. Unpublished results.
3. Akrigg, A., G. W. Wilkinson, S. Angliss, and P. J. Greenaway. 1991. HIV-1 indicator cell lines. AIDS 5:153-158.
4. Ansorge, W. 1982. Improved system for capillary microinjection into living cells. Exp. Cell Res. 140:31-37.
5. Brasseur, R., P. Lorge, E. Goormaghtigh, J.-M. Ruysschaert, D. Espion, and A. Burny. 1988. The mode of insertion of the paramyxovirus F1 N-terminus into lipid matrix, an initial step in host cell/virus fusion. Virus Genes 4:325-332.
6. Capecchi, M. R. 1980. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 22:479-488.
7. Ceriotti, A., and A. Colman. 1990. Trimer formation determines the rate of influenza virus haemagglutinin transport in the early stages of secretion in Xenopus oocytes. J. Cell Biol. 111:409-420.
8. Choppin, P. W., C. D. Richardson, D. C. Merz, W. W. Hall, and A. Scheid. 1981. The functions and inhibition of the membrane glycoproteins of paramyxoviruses and myxoviruses and the role of the measles virus M protein in subacute sclerosing panencephalitis. J. Infect. Dis. 143:352-363.
9. Choppin, P. W., and A. Scheid. 1980. The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev. Infect. Dis. 2:40-61.
10. Cochrane, A. W., C. H. Chen, and C. A. Rosen. 1990. Specific interaction of the human immunodeficiency virus rev protein with a structured region in the env mRNA. Proc. Natl. Acad. Sci. USA 87:1198-1202.
11. Cook, K. S., G. J. Fisk, J. Hauber, N. Usman, T. J. Daly, and J. R. Rusche. 1991. Characterization of HIV-1 Rev protein: binding stoichiometry and minimal RNA substrate. Nucleic Acids Res. 19:1577-1583.
12. Crise, B., A. Ruusala, P. Zagouras, A. Shaw, and J. K. Rose. 1989. Oligomerization of glycolipid-anchored and soluble forms of the vesicular stomatitis virus glycoprotein. J. Virol. 63:5328-5333.
13. Dayton, A. I., E. F. Terwilliger, J. Potz, M. Kowalski, J. G. Sodroski, and W. A. Haseltine. 1988. cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus. J. Acquired Immune Defic. Syndr. 1:441-452.
14. Dayton, E. T., D. A. M. Konings, D. M. Powell, B. A. Shapiro, L. Butini, J. V. Maizel, and A. I. Dayton. 1992. Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 Rev protein. J. Virol. 66:1139-1151.
15. Dayton, E. T., D. M. Powell, and A. I. Dayton. 1989. Functional analysis of CAR, the target sequence for the rev protein of HIV-1. Science 246:1625-1629.
16. Dewar, R. L., M. B. Vasudevachari, V. Natarajan, and N. P. Salzman. 1989. Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport. J. Virol. 63:2452-2456.
17. Earl, P. L., R. W. Doms, and B. Moss. 1990. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 87:648-652.
18. Eisenberg, D., E. Schwarz, M. Komaromy, and R. Wall. 1984. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol. 179:125-142.
19. Emerman, M., R. Vazeux, and K. Peden. 1989. The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell 57:1155-1165.
20. Feinberg, M. B., R. F. Jarrett, A. Aldovini, R. C. Gallo, and F. Wong-Staal. 1986. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 46:807-817.
21. Felber, B. K., M. Hadzopoulou-Cladaras, C. Cladaras, T. Copeland, and G. N. Pavlakis. 1989. Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86:1495-1499.
22. Felser, J. M., T. Klimkait, and J. Silver. 1989. A syncytia assay for human immunodeficiency virus type 1 (HIV-1) envelope protein and its use in studying HIV-1 mutations. Virology 170:566-570.
23. Freed, E. O., E. L. Delwart, G. L. Buchschacher, Jr., and A. T. Panganiban. 1992. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl. Acad. Sci. USA 89:70-74.
24. Freed, E. O., D. J. Myers, and R. Risser. 1990. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. USA 87:4650-4654.
25. Gallaher, W. R. 1987. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell 50:327-328.
26. 2-terminal sequence generated during precursor activation. Proc. Natl. Acad. Sci. USA 75:2737-2740.
27. Gonzalez-Scarno, F., M. N. Waxham, A. M. Ross, and J. A. Hoxie. 1987. Sequence similarities between human immunodeficiency virus gp41 and paramyxovirus fusion proteins. AIDS Res. Hum. Retroviruses 3:245-252.
28. Gorman, C. M., B. H. Howard, and R. Reeves. 1983. Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. Nucleic Acid Res. 11:7631-7648.
29. Hadzopoulou-Cladaras, M., B. K. Felber, C. Cladaras, A. Athanassopoulos, A. Tse, and G. N. Pavlakis. 1989. The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J. Virol. 63:1265-1274.
30. Hammarskjöld, M.-L., J. Heimer, B. Hammarskjöld, I. Sangwan, L. Albert, and D. Rekosh. 1989. Regulation of human immunodeficiency virus env expression by the rev gene product. J. Virol. 63:1959-1966.
31. Heaphy, S., C. Dingwall, I. Ernberg, M. J. Gait, S. M. Green, J. Kam, A. D. Lowe, M. Singh, and M. A. Skinner. 1990. HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev responsive element region. Cell 60:685-693.
32. Horth, M., B. Lambrecht, M. C. L. Khim, F. Bex, C. Thiriart, J.-M. Ruyss-chaert, A. Burny, and R. Brasseur. 1991. Theoretical and functional analysis of the SIV fusion peptide. EMBO J. 10:2747-2755.
33. Horvath, C. M., and R. A. Lamb. 1992. Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion. J. Virol. 66:2443-2455.
34. Huang, X., T. J. Hope, B. L. Bond, D. McDonald, K. Grahl, and T. G. Parslow. 1991. Minimal rev-responsive element for type 1 human immunodeficiency virus. J. Virol. 65:2131-2134.
35. Kjems, J., and P. A. Sharp. 1993. The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6 · U5 small nuclear ribonucleoprotein in spliceosome assembly. J. Virol. 67:4769-4776.
36. Kowalski, M., L. Bergeron, T. Dorfman, W. Haseltine, and J. Sodroski. 1991. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein. J. Virol. 65: 281-291.
37. Kowalski, M., J. Potz, L. Basiripour, T. Dorfman, W. C. Goh, E. Terwilliger, A. Dayton, C. Rosen, W. Haseltine, and J. Sodroski. 1987. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351-1355.
38. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
39. Madden, P. J., A. G. Dalgleish, J. S. McDougal, P. R. Clapham, R. A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
40. Malim, M. H., and B. R. Cullen. 1993. Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Mol. Cell. Biol. 13:6180-6189.
41. Malim, M. H., J. Hauber, S.-Y. Le, J. V. Maizel, and B. R. Cullen. 1989. The HIV-1 rev irons-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (London) 338:254-257.
42. Malim, M. H., L. S. Tiley, D. F. McCarn, J. R. Rusche, J. Hauber, and B. R. Cullen. 1990. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell 60:675-683.
43. McCune, J. M., L. B. Rabin, M. B. Feinberg, M. Lieberman, J. C. Kosek, G. R. Reyes, and I. L. Weissman. 1988. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53:55-67.
44. Myers, G., B. Korber, J. A, Berzofsky, R. F. Smith, and G. N. Pavlakis. 1993. Human retroviruses and AIDS 1993. A compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N.M.
45. Olsen, H. S., P. Nelbock, A. W. Cochrane, and C. A. Rosen. 1990. Secondary structure is the major determinant for interaction of HIV rev protein with RNA. Science 247:845-848.
46. Owens, R. J., C. C. Tanner, M. J. Mulligan, R. V. Srinivas, and R. W. Compans. 1990. Oligopeptide inhibitors of HIV-induced syncytium formation. AIDS Res. Hum. Retroviruses 6:1289-1296.
47. Pinter, A., W. J. Honnen, S. A. Tilley, C. Bona, H. Zaghouani, M. K. Gorny, and S. Zolla-Pazner. 1989. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J. Virol. 63:2674-2679.
48. 2 viral polypeptides. Virology 105:205-222.
49. Rosen, C. A., E. F. Terwilliger, A. I. Dayton, J. G. Sodroski, and W. A. Haseltine. 1988. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 85:2071-2075.
50. Saiki, R. H., D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
51. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA-sequencing with chain termination inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
52. Schawaller, M., G. E. Smith, J. J. Skehel, and D. C. Wiley. 1989. Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. Virology 172:367-369.
53. Scheid, A., M. Graves, S. Silver, and P. W. Choppin. 1978. Studies on the structure and function of paramyxovirus glycoproteins, p. 181-193. In B. W. J. Mahy and R. D. Barry (ed.), Negative strand viruses and the host cell. Academic Press Ltd., London.
54. Server, A. E., J. A. Smith, M. N. Waxham, J. S. Wolinsky, and H. M. Goodman. 1985. Purification and amino-terminal protein sequence analysis of the mumps virus fusion protein. Virology 144:373-383.
55. Skehel, J. J., and M. D. Waterfield. 1975. Studies on the primary structure of the influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 72:93-97.
56. Slepushkin, V. A., G. V. Kornilaeva, S. M. Andreev, M. V. Sidorova, A. O. Petrukhina, G. R. Matsevich, S. V. Raduk, V. B. Grigoriev, T. V. Makarova, V. V. Lukashov, and E. V. Karamov. 1993. Inhibition of human immunodeficiency virus type 1 (HIV-1) penetration into target cells by synthetic peptides mimicking the N-terminus of the HIV-1 transmembrane glycoprotein. Virology 194:294-301.
57. Sodroski, J. G., W. C. Goh, C. A. Rosen, A. I. Dayton, F. E. Terwilliger, and W. A. Haseltine. 1986. A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature (London) 321:412-417.
58. Stein, B. S., and E. G. Engleman. 1990. Intracellular processing of the gp160 HIV-1 envelope precursor. J. Biol. Chem. 265:2640-2649.
59. Strebel, K., D. Daugherty, K. Clouse, D. Cohen, T. Folks, and M. A. Martin. 1987. The HIV 'A' (sor) gene product is essential for virus infectivity. Nature (London) 328:728-730.
60. Vonèche, V., I. Callebaut, B. Lambrecht, R. Brasseur, A. Burny, and D. Portetelle. 1993. Enhancement of bovine leukemia virus-induced syncytia formation by di- and tripeptides. Virology 192:307-311.
61. Vonèche, V., D. Portetelle, R. Kettmann, L. Willems, K. Limbach, E. Paoletti, J. M. Ruysschaert, A. Burny, and R. Brasseur. 1992. Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells. Proc. Natl. Acad. Sci. USA 89:3810-3814.